Vascular calcification
Conditions
Interventions
Healthy control group:N/A
Hemodialysis group:N/A
Sponsors
Zhong Da Hospital, Southeast University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Healthy control group: Age greater than or equal to 18 years;Signed informed consent; Previous CT plain chest, abdomen and pelvis at our hospital between June 1, 2023 and June 1, 2024; Hemodialysis patient group: regular hemodialysis population; Dialysis age = 6 months; Dialysis 3 times a week; During the period from June 1, 2023 to June 1, 2024, I underwent plain CT scans of the chest, abdomen, and pelvis at our hospital; Voluntary signing of informed consent form.
Exclusion criteria
Exclusion criteria: Healthy control group: suffering from mental illness; Patients who cannot cooperate due to other reasons; Hemodialysis patient group: pregnancy/lactation; Patients with other autoimmune diseases; Suffering from malignant tumors, liver cirrhosis, acute and chronic congestive heart failure (left ventricular ejection fraction<45%), congenital heart disease, rheumatic heart disease, acute inflammation, etc; Diseases that affect bone metabolism and calcium phosphate homeostasis, such as primary hyperparathyroidism; Patients with incomplete clinical data;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IFITM3;SASP;Calcification score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Biological age; | — |
Countries
China
Contacts
Public ContactZhao Yu
Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, Jiangsu
Outcome results
None listed